recombinant human thrombopoietin (rHuTPO)

thrombopoietin · Shenyang Sunshine Pharmaceutical Co., LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant human thrombopoietin (rHuTPO), covering 2015-01-26 to 2015-01-26. Get the full timeline:

Most recent: Clinical Trial Update: The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC